Two-fifths of children have seen weight-loss drugs online despite ban
Abstract
A report from the Children’s Commissioner has revealed that two-fifths (41%; n=820) of children have seen adverts for prescription-only weight-loss drugs online — such as Ozempic (semaglutide; NovoNordisk), Mounjaro (tirzepatide; Eli Lilly) and Wegovy (semaglutide; NovoNordisk) — despite a ban on adverts for prescription-only weight-loss drugs in England. Results of a survey, published in the […]
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Pharmaceutical industry and healthcare
Smoking Behavior and Cessation
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026
- Language
- EN